2017 in Review: The Most-Read FFB Stories of 2017

December 22nd, 2017 by FFB Canada

At the FFB, we love writing about vision research. In 2017, we wrote more than 50 stories to share news about stem cell discoveries, CRISPR gene-editing, promising new drug therapies, and emerging treatments for blinding eye disease.

Have you read them all?

The best place to start is with our top 10 most-read stories of the year.

If you are wondering why there are so many stories about gene therapy on this list – start by reading the “4 Big Predictions for Vision Research in 2017” (which holds the #2 spot on the most-read list) and you’ll learn that we were pretty accurate! Also, we actually added the 11th place story too because we are very proud of the Clinician-Scientist Emerging Leader program, which launched in 2017!

  1. 1. CRISPR Breakthrough: Restoring Vision by Reprogramming Cells
  2. 2. 4 Big Predictions for Vision Research in 2017
  3. 3. Restore Vision 20/20: New Initiative Opens Up Greater Potential for Discovery
  4. 4. First Gene Therapy for a Blinding Eye Disease Receives FDA approval
  5. 5. Experimental Gene Therapy Completes Critical Regulatory Step
  6. 6. Clinical Trial Updates: Gene Therapy
  7. 7. Gene Therapy Improves Vision in Landmark Clinical Trial
  8. 8. The Biology of Treating Blindness with Stem Cells
  9. 9. Scientists are Developing an Eye Drop to Treat Inherited Blinding Eye Diseases
  10. 10. Everything You Need to Know About Genetic Testing for Inherited Retinal Diseases
  11. 11. Clinician-Scientist Emerging Leader Award: Dr. Brian Ballios